| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Zogenix Inc (NASDAQ: ZGNX)
ZGNX Technical Analysis
5
| As on 7th Mar 2022 ZGNX STOCK Price closed @ 26.68 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 19.00 & Strong Buy for SHORT-TERM with Stoploss of 20.55 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ZGNXSTOCK Price
| Open | 26.68 | Change | Price | % |
| High | 26.68 | 1 Day | 0.00 | 0.00 |
| Low | 26.68 | 1 Week | 0.52 | 1.99 |
| Close | 26.68 | 1 Month | 0.70 | 2.69 |
| Volume | N/A | 1 Year | 9.10 | 51.76 |
| 52 Week High 26.68 | 52 Week Low 11.25 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| APTO | 0.28 | 64.71% |
| NVDA | 134.70 | 3.08% |
| TNXP | 0.61 | 7.02% |
| LCID | 3.02 | 14.83% |
| TAOP | 0.41 | 28.12% |
| AVGO | 220.79 | 1.13% |
| TSLA | 421.06 | -3.46% |
| QUBT | 17.62 | 16.38% |
| AAPL | 254.49 | 1.88% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ZGNX Daily Charts |
ZGNX Intraday Charts |
Whats New @ Bazaartrend |
ZGNX Free Analysis |
|
|
ZGNX Important Levels Intraday
| RESISTANCE | 26.68 |
| RESISTANCE | 26.68 |
| RESISTANCE | 26.68 |
| RESISTANCE | 26.68 |
| RESISTANCE | 26.68 |
| RESISTANCE | 26.68 |
| RESISTANCE | 26.68 |
| RESISTANCE | 26.68 |
ZGNX Forecast December 2024
| 4th UP Forecast | 34.97 |
| 3rd UP Forecast | 32.31 |
| 2nd UP Forecast | 30.67 |
| 1st UP Forecast | 29.02 |
| 1st DOWN Forecast | 24.34 |
| 2nd DOWN Forecast | 22.69 |
| 3rd DOWN Forecast | 21.05 |
| 4th DOWN Forecast | 18.39 |
ZGNX Weekly Forecast
| 4th UP Forecast | 32.23 |
| 3rd UP Forecast | 30.45 |
| 2nd UP Forecast | 29.35 |
| 1st UP Forecast | 28.25 |
| 1st DOWN Forecast | 25.11 |
| 2nd DOWN Forecast | 24.01 |
| 3rd DOWN Forecast | 22.91 |
| 4th DOWN Forecast | 21.13 |
ZGNX Forecast2024
| 4th UP Forecast | 57.26 |
| 3rd UP Forecast | 47.45 |
| 2nd UP Forecast | 41.39 |
| 1st UP Forecast | 35.33 |
| 1st DOWN Forecast | 18.03 |
| 2nd DOWN Forecast | 11.97 |
| 3rd DOWN Forecast | 5.91 |
| 4th DOWN Forecast | -3.9 |
Zogenix Inc ( NASDAQ USA Symbol : ZGNX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ZGNX Business Profile
Zogenix, Inc., a biopharmaceutical company, develops and commercializes therapies to transform the lives of patients and their families living with rare diseases in the United States. The company's lead product candidate is the Fintepla, a low-dose fenfluramine, which is in Phase III clinical trials for the treatment of seizures associated with Dravet syndrome, as well as to treat seizures associated with Lennox-Gastaut syndrome; and that is in Phase II clinical trials for the treatment of other rare epileptic syndromes and diseases. It is also developing MT1621, an investigational therapy for the treatment of a rare genetic disorder called thymidine kinase 2 deficiency. Zogenix, Inc. has a collaboration with Tevard Biosciences for the research, development and commercialization of novel gene therapies for Dravet Syndrome and other genetic epilepsies. The company was formerly known as SJ2 Therapeutics, Inc. and changed its name to Zogenix, Inc. in August 2006. Zogenix, Inc. was incorporated in 2006 and is headquartered in Emeryville, California. Address: 5959 Horton Street, EmeryVille, CA, United States, 94608
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service